2018 International Congress Archives - Page 59 of 177

A 15-year review of a movement disorder database in Singapore

A. Wong, S. Neo, H.L. Ng, W. Li, K.Y. Tay, W.L. Au, L. Tan (Singapore, Singapore)
A bayesian network approach for prediction of future dementia in Parkinson’s disease

P. Surathi, M. Mirian, K. Sundvick, S. Appel-Cresswell, M. McKeown (Vancouver, BC, Canada)
A case of early onset parkinsonism caused by PLA2G6 gene mutation

L. Chen, S. Xu (Guangdong, China)
A case of levodopa responsive rapid onset dystonia-parkinsonism

Y. Fernandez, S. Frucht (New York, NY, USA)
A Case of Paraneoplastic Myoclonus Attributed to Non-Small Cell Lung Cancer

J. Nichols (Portland, OR, USA)
A Case of Parkinsonism due to the Hypoxic-Ischemic Lesions of the Striatum

H. Kaleagasi, N. Oksuz, O. Dogu (Mersin, Turkey)
A Case of Secondary Myoclonic Hyperkinesia

K. Harutyunyan, H. Amirjanyan, I. Gabrielyan, C. Asatryan, L. Galstyan, S. Khachaturyan, G. Avagyan, H. Manvelyan (Yerevan, Armenia)
A case of tardive dyskinesia and parkinsonism following use of phentermine for weight loss

R. Barmore, C. Hess, N. McFarland, M. Okun (Gainesville, FL, USA)
A case report of an Egyptian family with a rare condition of choreoacanthocytosis and amyotrophy

A. Dahshan, S. Ahmed, A. Hasan, A.S. Othman, D. Mekkawy, O. Yakoub, D. Abdulatif, Y. Gamil (Cairo, Egypt)
A clinical and pathological study of small fibers in Friedreich´s Ataxia

E. Indelicato, W. Nachbauer, A. Eigentler, A. Fanciulli, J.P. Ndayisaba, W. Poewe, G. Wenning, J. Wanschitz, S. Boesch (Innsbruck, Austria)
A clinical tool to ensure delivery of modern personalised medicine for Parkinson’s disease: first description of a personalised medicine checklist

N. Titova, K. Ray Chaudhuri (Moscow, Russian Federation)
A comparative study on the alterations in the cortical excitability and central motor conduction time in spinocerebellar ataxias 1, 2, 3 and 12

A. Stezin, K. Jhujhunwala, N. Kamble, P. Pal (Bangalore, India)
A comparison of relative displacement by double integration with root mean square in the quantitative evaluation of gait ataxia by triaxial accelerometers

S. Shirai, I. Yabe, M. Matsushima, H. Sasaki (Sapporo, Japan)
A comprehensive digital biomarker active testing and passive monitoring suite for the remote and frequent assessment of motor symptom progression in Parkinson’s disease

K. Taylor, R. Postuma, F. Boess, F. Lipsmeier, T. Kilchenmann, L. Verselis, J. Soto, M. Koller, C. Gossens, A. Post, J. Sevigny, M. Lindemann (Basel, Switzerland)
A Computer-Aided Prescription Model for Parkinson’s Disease could predict the suitable drugs for Parkinson’s disease (PD) patients

Y. Pan, L. Zhang (Nanjing, China)
A controlled trial of ParkinSong singing groups to improve communication and wellbeing in Parkinson’s disease

J. Tamplin, A. Vogel, C. Marigliani, F. Baker, M. Morris (Southbank, Australia)
A cortical neural signature of motor interruption in patients with Parkinson’s disease and freezing of gait

J. Baarbé, M. Brown, U. Saha, K. Lizarraga, A. Weissbach, N. Drummond, C. Rinchon, P. Kapoor, J. Saravanamuttu, R. Chen (Toronto, ON, Canada)
A detailed clinical study of pain in 1957 participants with Parkinson’s disease

M. Silverdale, C. Kobylecki, L. Kass-Iliyya, P. Martinez-Martin, D. Grosset, M. Hu, M. Lawton, S. Cotterill, R. Chaudhuri, H. Morris, F. Baig, N. Williams, L. Hubbard (Manchester, United Kingdom)
A Diagnostic Algorithm for Pediatric Early Onset Ataxia

R. Brandsma, C. Verschuuren, H. Kremer, T. de Koning, M. de Koning-Tijssen, D. Sival (Groningen, Netherlands)
A Double-Blind, Randomized, Placebo-Controlled, Cross-Over Phase IIa Trial to Evaluate the Efficacy of CVXL-0107 on Parkinson-Related Symptoms and Levodopa-Induced Dyskinesia in Advanced Parkinson’s Disease

JC. Corvol, F. Durif, W. Meissner, JP. Azulay, R. Haddad, D. Bricout, X. Wang-Zhang, L. Benel, O. Rascol, Fr. NS-Park/F-CRIN Network (Paris, France)
A first-in-human clinical study to test the safety and preliminary efficacy of CDNF in Parkinson’s disease

H. Huttunen, S. Booms, J. Koskinen, M. Saarma (Espoo, Finland)
A Florbetapir [F18] amyloid PET Imaging study in Parkinson’s disease Dementia (PDD): The influence of amyloid deposition on cognitive status and course of disease progression

G. Palermo, G. Aghakhanyan, L. Tommasini, D. Frosini, D. Volterrani, U. Bonuccelli, R. Ceravolo (Pisa, Italy)
A founder French-Canadian GBA mutation, p.W378G, as a cause for synucleinopathies and Gaucher disease

Z. Gan-Or, J. Ruskey, S. Zhou, L. Roncière, A. Alam, D. Spiegelman, J. Trempe, R. Postuma, N. Dupre, D. Amato (Montreal, QC, Canada)
A framework to facilitate competence in practice for Parkinson’s Disease Nurse Specialists in the United Kingdom

H. Martin, J. Price, L. Ebenezer (Coventry, United Kingdom)
A functional micro-electrode mapping of ventral thalamus in Essential Tremor

D. Pedrosa, P. Brown, H. Cagnan, V. Visser-Vandewalle, J. Wirths, L. Timmermann, J. Stuart-Brittain (Marburg, Germany)
A German-Austrian multicenter, non-interventional, prospective study for the treatment with abobotulinumtoxinA injections in naïve and previously treated patients suffering from cervical dystonia

W. Jost, A. Schramm, M. Müngersdorf, A. Stenner, P. Schwingenschuh, P. Maisonobe, M. Koch, B. Haslinger (Wolfach, Germany)
A longitudinal PET study to assess progression of laterality in Parkinson’s disease

AA. Roussakis, N. Lao-Kaim, A. Martin-Bastida, P. Piccini (London, United Kingdom)
A longitudinal study of brain quantitative MRI analysis before and after diagnosis of progressive supranuclear palsy

K. Seo, T. Yamamoto, H. Kawasaki, A. Miyake, T. Hukuoka, Y. Nakazato, T. Takahasi, I. Matunari, H. Matuda, N. Tamura, N. Araki (Saitama, Japan)
A machine learning approach to determine the important patient characteristics for tremor prevalence and tremor irregularity in dystonia

S. Balta Beylergil, L. Scorr, A. Cotton, H. Jinnah, A. Shaikh (Cleveland, OH, USA)
A Mcleod syndrome family and novel XK gene mutation in China mainland

L. Xu, P. Hua, W. Liu (Nanjing, China)
A metabolomic signature of treated and drug-naïve patients with Parkinson disease: A pilot study

J. Troisi, A. Landolfi, C. Vitale, K. Longo, A. Cozzolino, M. Squillante, M.C. Savanelli, P. Barone, M. AmbonI (Salerno, Italy)
A multimodal motor skill balance training with rhythmical cues to improve and maintain balance control in Parkinson’s disease

T. Capato, J. Nonnekes, J. Tornai, I. Kayo, J. IntHout, E. Barbosa, N. de Vries, M. Piemonte, B. Bloem (Sāo Paulo, Brazil)
A nationwide epidemiological study of Parkinson’s disease in Korea using national health insurance database

WW. Lee, B. Jeon, BK. Kim, HJ. Kim (Seoul, Republic of Korea)
A new clinical and research smartphone application to assess tremor and bradykinesia in patients with movement disorders

C. Duval, J.F. Daneault, B. Carignan, C.É. Coderre, S. Bogard (Montreal, QC, Canada)
A new distinct spastic ataxia with hypomyelination: Clinical, neuroimaging and molecular expression of NKX6-2 mutations

V. Chelban, N. Kaya, M. Alsagob, S. Efthymiou, J. Vandrovcova, D. Lynch, K. Kloth, A. Chirita-Emandi, F. Alkuraya, N. Wood, H. Houlden (London, United Kingdom)
A New Scale to Measure Impairment in Patients with Writer’s Cramp

E. Shamim, O. Ahmad, T. Wu, P. Srivanitchapoom, P. Diomi, B. Karp, K. Alter, C. Toro, B. Hodsdon, S. Pandey, J. Park, S. Meunier, M. Hallett (Largo, MD, USA)
A new SPG4/SPAST mutation in an Italian family with hereditary spastic paraplegia and Alzheimer’s disease

A. Orlacchio, C. Montecchiani, R. Rumore, F. Gaudiello, M. Miele, C. Caltagirone, T. Kawarai (Rome, Italy)
A novel homozygous splice site mutation in the KIF1C gene (SPAX2, SPG58) found in a consanguineous turkish family

E. Grauer, N. Pluta, P. Müller, D. Zeller, C. Ip, J. Volkmann, E. Kunstmann, T. Musacchio (Würzburg, Germany)
A novel mGlu4 PAM alleviates motor symptoms in primate models of PD and of LID

D. Charvin, T. Di Paolo, E. Bezard, L. Gregoire, A. Takano, G. Duvey, E. Pioli, C. Halldin, R. Medori, F. Conquet (Plan-les-Ouates, Switzerland)
A novel mutation in VRK1 associated with distal spinal muscular atrophy

L. Li, L. Wang, Z. Lu, X. Sun, X. Suo, J. Li, J. Peng, R. Peng (Chengdu, China)
A novel non-nitrocatechol COMT inhibitor ODM-104 shows superior pharmacodynamic effects to entacapone

S. Janhunen, J. Venäläinen, J. Kaskinoro, L. Saloranta, J. Tuunainen (Turku, Finland)
A Novel Telerehabilitation Strategy to Prevent Falls in Parkinson’s Disease (PD)

C. Park, M. Afshari, J. Guenther, M. Patel, H. Bhide, C. Tanner, N. Galifianakis (San Francisco, CA, USA)
A panel of CSF and plasma biomarkers reveals novel biological insights into atypical parkinsonian syndromes

E. Jabbari, J. Woodside, N. Magdalinou, A. Lees, H. Zetterberg, H. (London, United Kingdom)
A patient with myotonic dystrophy type 1 and parkinsonism

J. Choi, J. Lee, H. Kim, B. Jeon (Seoul, Republic of Korea)
A Patient-Centered Decision-Making Algorithm for Deep Brain Stimulation Surgery in Parkinson’s Disease

S. Joza, K. Yen, F. Ba, J. Miyasaki (Edmonton, AB, Canada)
A Phase 2 Efficacy Study of CX-8998, a Potent and Selective T-Type Calcium (Cav3) Modulator in Parkinson’s disease Tremor (PDT) Patients: Design and Dose-Selection Rationale

S. Papapetropoulos, M. Lee, S. Boyer, M. Versavel (Cambridge, MA, USA)
A Phase 2A Study of Nilotinib in Patients with Advanced and Early Parkinson’s disease: Study Design

T. Simuni, B. Fiske, K. Merchant, C. Coffey, H. Matthews, R. Wyse, P. Brundin, D. Simon, M. Schwarzschild, D. Weiner, C. Venuto, L. Trusso, L. Baker, M. Kostrzebski, T. Ward, G. Rafaloff (Chicago, IL, USA)
A Phase 3 study of isradipine as a disease modifying agent in patients with early Parkinson disease(STEADY-PD III): Baseline characteristics and study update

R. Holloway, D. Oakes, T. Simuni, K. Hodgeman, B. Greco, S. Henderson, J. Lowell, S. Sharma, C. Tarolli, K. Biglan (Rochester, NY, USA)
A phase Ib trial studying the safety and tolerability of IRL790 in patients with Parkinson’s disease and levodopa-induced dyskinesia

P. Svenningsson, A. Johansson, D. Nyholm, P. Tsitsi, C. Sonesson, J. Tedroff (Stockholm, Sweden)
A Physiotherapy Exercise Program for Parkinson’s Disease Patients with Impaired Gait and Postural Control

J. Yeung, A. Lau, E. Chan, J. Chung, L. Chan (Hong Kong)
A pilot study of plasma ubiquitin carboxyl-terminal hydrolase L1 (UCH-L1) as a potential blood-based biomarker in Parkinson’s disease

A. Ng, YJ. Tan, ZH. Lu, S. Ng, E. Ng, F. Setiawan, N. Keong, WL. Au, EK. Tan, L. Tan (Singapore, Singapore)
A post-mortem and in vivo study of neuroinflammation and Toll like-receptors in Parkinson’s disease

A. Kouli, W.L. Kuan, K. Scott, X. He, R. Barker, C. Williams-Gray (Cambridge, United Kingdom)
A Preliminary Study of Cinnamomum verum on Anxiety, Locomotor Activity and Emotionality Behaviour in Wistar Albino Rats

N. Ahmed (Aligarh, India)
A promising model for cognitive dysfunction in Parkinson’s Disease by AAV-mediated alpha-synuclein overexpression in hippocampus

E. Cinar, G. Yalcin-Cakmakli, E. Saka, A. Ulusoy, B. Tel, B. Elibol (Ankara, Turkey)
A prospective MRI study of edema surrounding deep brain stimulation leads

L. Borellini, F. Cogiamanian, S. Sbaraini, E. Scola, G. Carrabba, M. Locatelli, S. Avignone, F. Mameli, F. Ruggiero, R. Ferrucci, G. Ardolino, S. Barbieri, P. Rampini (Milano, Italy)
A Psychometric Analysis of the MDS UPDRS-II and III in Early Parkinson’s disease: Do the Numbers Add Up?

A. Regnault, B. Boroodjerdi, J. Meunier, M. Bani, S. Cano (Lyon, France)
A randomized double-blind placebo-controlled trial of probiotics for constipation in Parkinson’s disease

K.K. Chong, S.Y. Lim, M.A.A. A Manap, J.L. Lim, S.C. Low, S. K Mahadeva, A.H. Tan (Kuala Lumpur, Malaysia)
A Randomized Trial of Deferiprone for Pantothenate Kinase-Associated Neurodegeneration

T. Klopstock, F. Tricta, L. Neumayr, I. Karin, G. Zorzi, C. Fradette, T. Kmieć, B. Buechner, H. Steele, R. Horvath, P. Chinnery, A. Basu, C. Küpper, C. Neuhofer, P. Dušek, F. Zhao, F. Zibordi, N. Nardocci, C. Aguilar, S. Hayflick, M. Spino, A. Blamire, P. Hogarth, E. Vichinsky (Munich, Germany)
A randomized, double-blind, placebo-controlled Phase II Efficacy and Safety Study of the PDE10A inhibitor PF-02545920 in Huntington Disease (AMARYLLIS)

M. Delnomdedieu, Y. Tan, A. Ogde, Z. Berger, R. Reilmann (Cambridge, MA, USA)
A Real-world Assessment of Hospitalizations Due to Falls among Patients with and without OFF episodes in Parkinson’s Disease

K. Rajagopalan, A. Lee, J. Barton, J. Pike (Marlborough, MA, USA)
A Registry of Real-World Outcomes Using Deep Brain Stimulation for the Treatment of Dystonia

J. Krauss, C. Nicholson, M. Barbe, V. Visser-Vanderwalle, A. Kuehn, M. Poetter-Nerger, R. Jain, H. Scholtes, N. Van Dyck, A. Albanese (Hannover, Germany)
A review of modifiers of Parkinsonism in the Leucine-rich repeat kinase 2 (LRRK2) population

J. Staisch (Portland, OR, USA)
A single center retrospective analysis of Opicapone treatment in 90 Parkinson patients

M. Winterholler, H. Erxleben (Schwarzenbruck, Germany)
A strategic approach to understand microsatellite repeat loci among Indian spinocerebellar ataxia patients

V. Suroliya, M. Faruq, A. Srivastava (New Delhi, India)
A study of correlation between screening tools for cognitive decline and gait status using three-dimensional gait analysis

PJ. Park (Busan, Republic of Korea)
A Study of Pain in Parkinson’s Disease

S. Meenakshisundaram, B. Samivel, T. Sundaram, LN. Ranganathan (Chennai, India)
A Study on Combined Brain Positron Emission Tomography (PET) – Magnetic Resonance Imaging (MRI) Using Fluorodeoxyglucose (18FDG) (FDG-PET/MRI) in Premanifest Huntington’s Disease Gene-expansion Carriers

M. Hellem, T. Vinther-Jensen, C. Hansen, E. Budtz-Jørgensen, L. Hjermind, I. Law, J. Nielsen (Copenhagen, Denmark)
A study on pre-adoption of a self-management application by Parkinson’s disease patients

M. Memedi, J. Lindqvist, T. Tunedal, A. Duvåker (Örebro, Sweden)
A Study to Evaluate the Efficacy of PRX002/RG7935 in Participants With Early Parkinson’s Disease (PASADENA) – Study Design

B. Mollenhauer, F. Boess, K. Marek, W. Poewe, R. Postuma, K. Taylor, J. Dukart, M. Lindemann, L. Verselis, M. Niggli, T. Barata, A. Post, M. Koller, D. Ness, D. Selkoe, J. Sevigny (Göttingen, Germany)
A Theranostic Approach to Intervene the Link Between Parkinson’s Disease (PD) and LRRK – 2 Mutation

P. Basavaraju, P. Moorthi (Coimbatore, India)
A unique case of DAT positive Parkinson’s disease along with a mutable Huntington’s gene

P. Prakash, S. Baser, M. Flaherty, T. Leichliter (Pittsburgh, PA, USA)
A Virtual Reality Exercise Program Improves the Balance Function and Quality of Life of Patients with Parkinson’s Disease

G. Lee (Cheonan, Republic of Korea)
A voxel-wise meta-analysis of gray matter abnormalities in essential tremor

Q. Han, Y. Hou, H. Shang (Chengdu, China)
A wireless brain-spine interface alleviating gait deficits of non-human primates model of Parkinson’s disease

F. Raschella, T. Milekovic, M. Perich, S. Sun, G. Schiavone, C. Hitz, Y. Jianzhong, W. Ko, Q. Li, C. Qin, S. Lacour, J. Bloch, S. Micera, E. Bezard, G. Courtine (Geneva, Switzerland)
A Young Man with Multiple System Atrophy: A Case Report

DR. Carneiro, M. Sousa, C. Januário, A. Morgadinho (Coimbra, Portugal)
A53T mutant human α-synuclein BAC transgenic mice as a model for Parkinson’s disease

T. Taguchi, I. Masashi, M. Uemura, Y. Hatanaka, N. Uemura, H. Yamakado, R. Takahashi (Kyoto, Japan)
Abnormal cerebellar learning in cervical dystonia

T. Bäumer, E. Tzvi, J. Junker, J. Verrel, S. Loens (Luebeck, Germany)
Abnormal Functional Connectivity in Cerebellar Locomotor Region is associated with the severity of freezing of gait in patients with Parkinson’s disease

K. Bearti, A. Suppa, S. Pietracupa, N. Upadhyay, C. Giannì, G. Leodori, F. Di Biasio, N. Modugno, N. Petsas, G. Grillea, A. Zampogna, A. Berardelli, P. Pantano (Rome, Italy)
Abnormal NMDA-related Electrophysiology in Parkinson Disease Dementia

J.C. Chen, H.M. Heng, C.H. Tsai (Taichung, Taiwan)
Abnormal signaling along the non-canonical molecular cascade GRK6/β-arrestin2/Akt/GSK-3β in the putamen is associated with tardive dyskinesia following chronic haloperidol exposure in a primate model

P. Blanchet, G. Hernandez, S. Mahmoudi, M. Cyr, J. Diaz, D. Levesque (Montreal, QC, Canada)
Abrogation of Rotenone Induced Behavior, Biochemical and Mitochondrial Deficits in Mice by Curcumin and Ginkgo Biloba: New Combinational Therapy Approach for Parkinson’s Disease

D. Khatri, M. Panchwadkar, P. Rane, V. Undale (Pune, India)
Absence of the nigrosome-1 area in 3 tesla resonance and its relation with hyperechogenicity of the substantia nigra in patients with Parkinson’s disease

J.S. Bestoso, M. Pérez Akly, L. Ciancaglini, C. Stefani C, J. Norscini, J. Funes, C. Besada, D. Bauso (Buenos Aires, Argentina)
Absence of wearing-off in Parkinson’s disease patients with treatment beyond 10 years

Q. Wei, R. Ou, Y. Wu, X. Yuan, Y. Hou, H. Liu, L. Zhang, Y. Chen, B. Cao, X. Chen, H. Shang (Chengdu, China)
Accelerometer-based measures and analyses of nonmotor symptoms of patients with Parkinson’s Disease

C. Virbel-Fleischman, Y. Retory, S. Hardy, J.C. Corvol, D. Grabli (Paris, France)
Accessing Speech and Language Therapy (SLT) in a Multi-Disciplinary Movement Disorders Clinic (MDC)

J. Martin, A. Chatterjee (Reading, United Kingdom)
Accuracy of the International Parkinson Disease and Movement Disorder Society Progressive Supranuclear Palsy Diagnostic Criteria (IPD-MDS-PSP)

A. Shoeibi, I. Litvan, J. Juncos, Y. Bordelon, D. Riley, S. Reich, D. Shprecher, D. Hall, C. Marras, B. Kluger, N. Olfati, J. Jankovic (Mashhad, Islamic Republic of Iran)
Acid sphingomyelinase deficiency rescues mitochondrial dysfunction in gba-/- zebrafish (Danio rerio)

M. Keatinge, L. Trollope, H. Mortiboys, O. Bandmann (Sheffield, United Kingdom)
Acoustic analysis and subjective vocal perception of Parkinson’s disease patients and healthy control and the relation to depression and quality of life

Y. Manor, S. Naor, D. Shpunt, N. Diamant, N. Zivion, L. Hayat, A. Yaron, A. Hillel, A. Ezra, I. Opher, Y. Hauptman, R. Aloni-Lavi, A. Faust-Socher, T. Gurevich (Tel Aviv, Israel)
Acoustic, respiratory, cognitive and wellbeing comparisons of two groups of people with Parkinson’s disease participating in voice and choral singing group therapy (VCST) versus a music appreciation activity

R. Matthews, S. Purdy, L. Tippett (Auckland, New Zealand)
Acoustical characteristics of speech impairment in Primary Generalized Dystonia

M.C. Cuartero, R. Bertrand, D. Grabli, M. Vidailhet, S. Pinto (Aix-en-Provence, France)
Activation of chaperone-mediated autophagy reduces oligomeric alpha-synuclein accumulation in LRRK2(R1441G) knockin mouse model of Parkinson’s disease (PD)

P.W.L. Ho, C.S.C. Lam, M.C.T. Leung, S.Y.Y. Pang, H.F. Liu, L. Li, M.H.W. Kung, D. Ramsden, SL. Ho (Hong Kong)
Activities of Daily Living and Quality of Life in Patients with Advanced Parkinson’s Disease Who Are Treated with or Planning to Use Device-Aided Treatments

A. Fasano, K. Seppi, V. Fung, Z. Pirtosek, J.C. Parra, L. Bergmann, O. Sanchez-Soliño, B. Elibol, K. Onuk (Toronto, ON, Canada)
Acute concomitant presentation of chorea and subacute combined degeneration secondary to vitamin B12 deficiency

E. Natera, F. Acebrón, A. Sánchez, V. Ros, A. Gómez, F. Ruiz, B. Zarza, C. Estévez, A. Alonso, JC. Martínez-Castrillo, I. Corral (Madrid, Spain)
Acute efficacy and tolerability of the COMT inhibitor opicapone

F. Gandor, D. Sykora, D. Gruber, G. Ebersbach (Beelitz-Heilstätten, Germany)
Acute Stroke in Middle Cerebellar Peduncle in a Patient with FXTAS

A. Fraint, D. Hall, R. Dafer (Chicago, IL, USA)
ADCY5-related disorder associated with status dystonicus

A. Castro Caldas, P. Pita Lobo, L. Correia Guedes, M. Coelho (Lisboa, Portugal)
Adolescent onset RBD converting to PD after 48 years

Z. Xu, J. Oliver, K. Anderson (Singapore, Singapore)
Adult neurogenesis is impaired in pink1-/- zebrafish (Danio rerio)

S. Bandmann, M. Keatinge, M. Placzek, O. Bandmann (Sheffield, United Kingdom)
Advanced Parkinson’s disease Diagnosis and Treatment Trends in Israel – Sub-Analysis of the OBSERVE-PD Multi-Country, Cross-Sectional Study

R. Djaldetti, S. Hassin-Baer, M. Anca-Herschkovitsch, R. Gross, R. Cohen, H. Banayan, K. Onuk, T. Gurevich (Petah Tikva, Israel)
Affective impairment and emotional tone of early Richardson’s syndrome and Progressive Supranuclear Palsy with predominant parkinsonism: The role of Alexithymia and Anhedonia

C. Pellicano, F. Assogna, L. Cravello, C. Savini, M. Pierantozzi, A. Stefani, B. Mercuri, C. Caltagirone, F. Pontieri, G. Spalletta (Rome, Italy)
Affective Theory of Mind Impaired in Parkinson’s Disease: Negative- and Neutral- specific impairments of Emotion State Decoding

C.H. Tan, S.C. Tu, R.L. Yu (Kaohsiung, Taiwan)
After Deep Brain Stimulation Surgery for Parkinson’s Disease risk Factors for Postoperative Delirium

F. Rakhimov, G. Rakhimbaeva (Tashkent, Uzbekistan)
Age related changes of cortical effective connectivity during bimanual motor control

P. Loehrer, F. Nettersheim, I. Weber, F. Jung, L. Timmermann (Marburg, Germany)
Agreement Between Patients and Informants on the Penn Parkinson’s Daily Activity Questionnaire

B. Deck, S. Xie, J. Rick, A. Chen-Plotkin, J. Duda, J. Morley, N. Dahodwala, J. Trojanowski, D. Weintraub (Philadelphia, PA, USA)
Alleviation of freezing of gait in patients with Parkinson’s disease by high-frequency rTMS over SMA is associated with normalization of brain connectivity patterns

T.M. Mi, S. Garg, F. Ba, T. Wu, P.P. Liang, L.L. Gao, K.C. Li, P. Chan, M. McKeown (Beijing, China)
Alpha-synuclein oligomer and rotenone treatments injury the dopaminergic neuron via inhibiting the expression of gene SEMA6D

X. Yingyu (Guangzhou, China)
Alteration of the fecal microbiota in Chinese patients with Parkinson’s disease

Y. Xiaodong, Q. Yiwei, X. Shaoqing, C. Shengdi, X. Qin (Shanghai, China)
Alteration to Basal Ganglia Morphology in Freezing of Gait in Parkinson’s Disease

N. D'Cruz, G. Vervoort, W. Vandenberghe, A. Nieuwboer (Leuven, Belgium)
Alterations of cerebello-cortical networks related to the cognitive performance in multiple system atrophy

K. Hara, H. Watanabe, K. Kawabata, E. Bagarinao, R. Ohdake, M. Masuda, T. Yokoi, A. Ogura, T. Tsuboi, M. Ito, M. Katsuno, G. Sobue (Nagoya, Japan)
Alterations of cortical metabotropic glutamate receptor-mediated signaling in patients with Parkinson’s disease

JY. Lee, YK. Kim, SA. Shin, SH. Seo, JS. Lee, YS. Lee, JM. Jeong, B. Jeon (Seoul, Republic of Korea)
Alterations of the intestinal microbiota were correlated with the severity of Tourette syndrome in children

WT. Lee, LC. Wong (Taipei, Taiwan)
Altered amplitude of low-frequency fluctuations and functional connectivity in excessive daytime sleepiness in Parkinson disease

X. Wang, K. Zhang (Nanjing, China)
Altered connectivity in ventral and dorsal attentional networks in patients with Parkinson’s disease: Association with freezing of gait

I. Maidan, Y. Jacob, N. Giladi, J. Hausdorff, A. Mirelman (Tel Aviv, Israel)
Altered putamen and cerebellum connectivity between different subtypes of Parkinson’s disease

B. Shen, L. Zhang (Nanjing, China)
Alternating thalamic deep brain stimulation for Essential Tremor: A trial to reduce habituation

M. Seier, A. Hiller, J. Quinn, C. Murchison, M. Brodsky, S. Anderson (Omaha, NE, USA)
Alzheimer’s Disease Genetic Risk Variants Predict Cognitive Decline in Parkinson’s Disease

T. Tropea, K. Maddy, J. Rick, J. Trojanowkski, D. Weintraub, A. Chen-Plotkin (Philadelphia, PA, USA)
Amantadine extended release (Gocovri) reduces dyskinesia and bradykinesia: Evaluation of clinical response with the wearable PKG (Personal Kinetigraph) watch

N. Chhabria, S. Isaacson, K. Lyons, R. Pahwa (Boca Raton, FL, USA)
Ambulosono – A Music Walking Program Improves Gait Disorders in Parkinson’s Disease

W. Xian, B. Hu, T. Wu, L. Jiang, L. Chen, Z. Pei (Guangzhou, China)
Amyloid deposition affects cognitive manifestations in Parkinson’s disease: The PPMI dataset

E. Fiorenzato, R. Biundo, D. Cecchin, AC. Frigo, L. Weis, J. Kim, A. Strafella, A. Antonini (Venice, Italy)
Amyloid PET and cognition in Parkinson’s disease

T. Melzer, M. Stark, D. Myall, R. Keenan, L. Livingston, M. Almuqbel, M. MacAskill, T. Pitcher, K. Horne, S. Grenfell, M. Pascoe, B. Young, J. Wang, S. Marsh, D. Miller, J. Dalrymple-Alford, T. Anderson (Christchurch, New Zealand)
Amyotrophic Lateral Sclerosis-Progressive Supranuclear Palsy Phenotype with Negative C9ORF72 Mutation

S.C. Low, A.H. Tan, M. Ellis, K.J. Goh, S.Y. Lim, A. Ahmad-Annuar, N. Shahrizaila, M. Kennerson (Kuala Lumpur, Malaysia)
An analysis of cortical thickness in early Parkinson’s disease patients with cognitive impairment

M. Mei, K. Nie, Y. Gao, Y. Zhang, L. Wang (Guangzhou, China)
An atutopsy case of argyrophilic grain disease, clinically presenting with Parkinson dementia

R. Sengoku, D. Kaneda, M. Kameyama, A. Tokumaru, K. Ishii, K. Kanemaru, Y. Saito, S. Murayama (Tokyo, Japan)
An automated algorithm for detection and quantification of tremor from pen-on-paper Archimedes spirals

R. Rajan, A. R, A. Pandit, V. Venugopalan, D. Vibha, S. Krishnan, A. Srivastava, K. Prasad, A. Kishore (New Delhi, India)
An early-onset parkinsonism revealing a Gaucher disease with a heterozygous mutation in GBA gene: A case report

R. Zouari, S. Ben Romdhan, N. Farhat, S. Sakka, H. Haj Kacem, O. Hdiji, M. Dammak, C. Mhiri (Sfax, Tunisia)
An efficient algorithm for predicting pathological high-voltage spindles related to Parkinsonian resting tremor from local field potential recordings

R. Perumal, V. Vigneron, C. Chuang, Y. Chang, S. Yeh, H. Chen (Hsinchu, Taiwan)
An EMG-Motion capture analysis of Golfers with the Yips

G. Revankar, I. Ogasawara, Y. Kajiyama, N. Hattori, Y. Uno, K. Konaka, Y. Gon, M. Mihara, S. Kawamura, K. Nakata, H. Mochizuki (Osaka, Japan)
An evaluation of the availability and format of information provided to patients who have a new diagnosis of Parkinson’s disease (PD)

L. Ebenezer, J. Price, H. Martin (Bridgend, United Kingdom)
An extraordinary cause of psychosis: Anti-NMDA receptor encephalitis

H. Batur Caglayan, F. Sahin, T. Altıparmak, E. Turksoy, S. Candansayar, A. Bora Tokcaer (Ankara, Turkey)
An international survey of stiff person spectrum disorders: Exploring the clinical spectrum and unmet needs

B. Balint, E. Gatto, J. Etcheverry, M. Cesarini, V. Virginia Parisi, M. Rodriguez Violante, P. Garcia Ruiz, K. Bhatia (London, United Kingdom)
An investigation of the potential neuroprotective role of curcumin in Parkinson’s disease patient-derived fibroblasts

S. Abrahams, C. vander Merwe, A. Neethling, J. Carr, S. Bardien (Cape Town, South Africa)
An investigation of the relationship between computational neuropsychological testing outcomes and symptoms of Parkinson’s disease

L. Jiang, Y. Zhu, Z. Ye, Z. Pei, L. Chen (Guangzhou, China)
An Objective Tool to Guide Target Selection for DBS in PD (GPi vs STN) – integration into Thomas Jefferson’s multidisciplinary Movement Disorders Center

L. Meytin, TW. Liang, J. Ratliff (Philadelphia, PA, USA)
An Observational Study Using Multimodal Wearable Sensors and Environmental Monitors in Healthy Volunteers to Characterize Activities Pertaining to Health, Wellbeing, and Daily Living

T. Kangarloo, F. Hameed, C. Demanuele, D. Psaltos, H. Zhang, R. Lopez, S. Amato, K. Hallock, X. Cai (Cambridge, MA, USA)
An oculogyric crisis after administation of alizapride: A tardive phenomenon?

A. Boogers (Edegem, Belgium)
An open labeled, observational study for the Satisfaction and Preference of the Rivastigmine patch for treatment of Alzheimer’s disease and Parkinson’s disease dementia (SAFE-ADPD) in Koreans

M. Park, D. Shin (Daegu, Republic of Korea)
An Unusual Case of Peripheral Myoclonus

M. de Lima (Phoenix, AZ, USA)
Analysis of gene polymorphisms of Parkinson’s disease in Han Chinese population

H. Jin, J. Zhang, K. Li, C. G, C. Liu (Suzhou, China)
Analysis of secondary causes in Fahr’s syndrome and whole exome sequencing in Fahr disease from Northeast China and South Korean

G. Shen, B. Jeon, G. Nan, S. Park (Changchun, China)
Analysis of sensory tricks in 45 patients with pantothenate kinase-associated neurodegeneration

J. Martins, A. Darling, C. Garrido, C. Espinós, B. Dueñas, T. Temudo (Porto, Portugal)
Analysis of Tau Burden and Distribution on the Spectrum of PSP Subtypes

J. Sanchez-Ruiz Gordoa, P. Clavero, M. Zelaya, C. López-Molina, A. Galbete, V. Coca, M. Mendioroz, E. Erro (Pamplona, Spain)
Analysis of the electromyographic profile of a subject with spasticity during the lateral reactive postural control test

M. Maldonado (Santiago, Chile)
Anemia in men and increased Parkinson’s disease risk: A population-based cohort study using big data

V. Rozani, N. Giladi, B. El-Ad, T. Gurevich, J. Tsamir, B. Hemo, C. Peretz (Tel Aviv, Israel)
Angiotensin-converting enzyme inhibitors are neuroprotective regarding APOE-mediated motor and non-motor experiences for Alzheimer’s dementia but not for dementia with Lewy bodies

F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti (São Paulo, Brazil)
Ankle proprioception and postural instability in Parkinson’s disease

H. Teasdale, E. Preston, W. Spratford, G. Waddington (Bruce, Australia)
Annual Clinical Evaluation in Out Patient Clinic May Improve Quality of Life in Patients with Parkinson’s Disease

M. Tomiyama, T. Ueno (Aomori, Japan)
Anti-glutamatergic effect of safinamide in Parkinson’s Disease: A TMS study

A. Guerra, A. Suppa, V. D'Onofrio, F. Di Stasio, F. Asci, G. Fabbrini, A. Berardelli (Rome, Italy)
Antibodies to alpha-Synuclein in Parkinson disease

D. Labunskiy (Santa Rosa, CA, USA)
Antiglycine Receptor Antibodies and Rapidly Progressive Corticobasal Syndrome

A. Muñoz González, A. Contreras Chicote, M. Vales Montero, J.M. Velázquez Pérez, B. Dela Casa, E. Luque Buzo, F. Graus, F. Grandas (Madrid, Spain)
Antihypertensive medications have protective associations with PD outcomes in PD-hypertension

V. Kotagal (Ann Arbor, MI, USA)
Antisense FMR1 splice variant: A predictor of fragile X-associated tremor/ataxia syndrome

P. Vittal, S. Pandya, K. Sharp, E. Berry-Kravis, L. Zhou, B. Ouyang, J. Jackson, D. Hall (Winfield, IL, USA)
Apathy in Parkinson’s disease is associated with abnormal alpha oscillatory behaviour during incentivized movement

M. Zhu, S. Garg, A. HajiHosseini, S. Appel-Cresswell, M. McKeown (Vancouver, BC, Canada)
Apathy in Parkinson’s disease is associated with REM sleep behavior disorder

F. Ricordeau, M. Figorilli, A. Marques, T. Vidal, B. Beudin, B. Debilly, P. Derost, M. Puligheddu, F. Durif, M.L. Fantini (Clermont Ferrand, France)
Apathy in rapid eye movement sleep behaviour disorder is associated with serotonin depletion in the raphe nuclei

T. Barber, L. Griffanti, K. Muhammed, D. Drew, K. Bradley, D. McGowan, M. Crabbe, C. Lo, C. Mackay, M. Husain, M. Hu, J. Klein (Oxford, United Kingdom)
Apolipoprotein E and multiple system atrophy

K. Ogaki, Y. Martens, M. Heckman, S. Koga, L. Labbé, O. Lorenzo-Betancor, A. Wernick, R. Walton, A. Soto, E. Vargas, H. Nielsen, S. Fujioka, T. Kanekiyo, R. Uitti, J. van Gerpen, W. Cheshire, Z. Wszolek, P. Low, W. Singer, N. Hattori, D. Dickson, G. Bu, O. Ross (Tokyo, Japan)
Application of Chinese version of SWAL-QOL in Parkinson’s Disease

H.F. Chan, H. Kim, M. Ng, DY. Kim (Seoul, Republic of Korea)
Application of the Movement Disorder Society Prodromal Criteria in healthy G2019S-LRRK2 carriers

A. Mirelman, R. Saunders-Pullman, R. Alcalay, S. Shustak, A. Thaler, B. Cohen, A. Hillel, T. Gurevich, D. Raymond, H. Mejia-Santana, L. Ozelius, L. Clark, M. Gana-Weisz, A. Bar-Shira, A. Orr-Urtreger, S. Bressman, K. Marder, N. Giladi (Tel Aviv, Israel)
Applying Intervention Mapping methodologies to enhance Data Completeness in Movement Disorders-related Scales

C. Goetz, S. Luo, G. Stebbins (Chicago, IL, USA)
Approach to Health Care Shaped by Generational Expectations (The AGE Study): Patients’ preferences for healthcare providers

D. Hengartner, T. Rasameesoraj, J. Lin, O. Hogue, Y. Li, O. Wenzel, E. LaPlante, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)
Approaching Health Care Shaped by Generational Expectations (The AGE Study): A perspective on technology and research

T. Rasameesoraj, D. Hengartner, J. Lin, O. Hogue, E. LaPlante, Y. Li, O. Wenzel, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)
Approaching Health Care Shaped by Generational Expectations (The AGE Study): Generational Perspective Related to Time

J. Lin, D. Hengartner, T. Rasameesoraj, O. Hogue, Y. Li, O. Wenzel, E. LaPlante, J. Liang, H. Fernandez, X. Yu (Cleveland, OH, USA)
Are Lewy bodies associated with sympathetic pathology in dementia subjects?

D. Shprecher, M. Callan, B. Cutler, G. Serrano, C. Adler, H. Shill, J. Caviness, M. Sabbagh, C. Belden, E. Driver-Dunckley, S. Mehta, L. Sue, K. Davis, E. Zamrini, T. Beach (Sun City, AZ, USA)
Are the MDS-UPDRS-based composite scores clinically applicable?

N. Kovács, A. Juhász, Z. Aschermann (Pécs, Hungary)
ARISE study: Study Design and Baseline Characteristics for a Phase 2 Trial of the Anti-Tau Antibody ABBV-8E12 in Progressive Supranuclear Palsy

N. Mendonca, R. Bateman, A. Boxer, J. Braunstein, D. Claassen, D. Holtzman, D. Kerwin, B. Rendenbach-Mueller, H. Soares, D. Wang, G. Höglinger (Ludwigshafen, , Germany)
Arm swing asymmetry in Parkinson Disease patients using a portable RGBD camera

J. Orozco, B. Munoz, J. Valderrama, A. Navarro, Y. Castaño, J. Arango (Cali, Colombia)
Artisanal formulations of Cannabis in Movement Disorders. The real-life perspective in a population from Buenos Aires, Argentina. Preliminary report

M. Cesarini, JL. Etcheverry, N. Gonzalez Rojas, G. Da Prat, V. Parisi, G. Rojas, G. Persi, E. Gatto (Buenos Aires, Argentina)
Assessing hemifacial spasm: The HFSG scale

S. Simoni, N. Tambasco, E. Sacchini, E. Marsili, P. Nigro, E. Brahimi, M. Romoli, F. Paolini Paoletti, M. Filidei, P. Calabresi (Perugia, Italy)
Assessing the Effectiveness of Valbenazine in the Treatment of Tardive Dyskinesia as Determined by the AIMS and PGIC: Results from the KINECT 4 Trial

C. Singer, C. Comella, K. Farahmand, J. Burke, R. Jimenez, S. Siegert (Miami, FL, USA)
Assessing the potential cost-effectiveness of ads-5102 (Amantadine HCl) for the treatment of dyskinesia in Parkinson’s disease patients

R. Pahwa, L. Garrison, M. Zimmerman, R. Johnson, J. Nguyen, M. Li, R. Patni (Kansas City, KS, USA)
Assessing the potential of EEG as a biomarker in Huntington’s disease using machine learning automatic classification

O. Odish, K. Johnsen, P. van Someren, R. Roos, G. van Dijk (Leiden, Netherlands)
Assessing the Quality of Economic Evaluation of Treatment Options for Parkinson’s disease Using the Quality of Health Economic Studies (QHES) Scale

M. Azharuddin, M. Adil, P. Ghosh, M. Sharma (New Delhi, India)
Assessing working memory dysfunction with letter n-back functional MRI task in early-stage Parkinson’s disease

A. Martin-Bastida, N. Lao-Kaim, S. Pietracupa, M. Wall, A. Roussakis, Y. Xing, S. Schwarz, D. Auer, P. Piccini (London, United Kingdom)
Assessment of clinical peculiarities of violations of vertical vision in patients with Parkinson’s disease

M. Salokhiddinov, D. Akramova (Tashkent city, Uzbekistan)
Assessment of cognitive functions, depression-anxiety scales and quality of life in patients and their relatives with Cervical Dystonia and Botulinum Toxin Treatment

D. Ceylan, S. Erer, M. Zarifoglu, N. Turkes, A. Demiralay (Bursa, Turkey)
Assessment of CSF biomarkers clinical value in Progressive Supranuclear Palsy

T. Schirinzi, G. Sancesario, G. Di Lazzaro, N. Mercuri, S. Bernardini, A. Lang, A. Pisani (Rome, Italy)
Assessment of Motor Symptoms in Parkinson’s disease using Flexible Wearable Sensors and Deep Neural Networks: A CIS-PD substudy

L. Lonini, A. Dai, C. Poon, N. Shawen, L. Shimanovich, T. Simuni, D. Daeschler, J. Rogers, A. Jayaraman (Chicago, IL, USA)
Assessment of pain and its correlation with quality of life in Parkinson’s disease

K. Anand, A. Agrawal, P. Kumar (New Delhi, India)
Association analysis of miRNA-linked variants with Parkinson’s disease and multiple system atrophy in a large Chinese population

X.J. Gu, Y.P. Chen, B. Cao, R.W. Ou, Q.Q. Wei, B. Zhao, Y. Wu, W. Song, H.F. Shang (Chengdu, People’s Republic of China)
Association analysis of the nutritional status and serum nutritional index in patients with Parkinson’s disease

L. Chen, W. Chen, Q. Guo, L. Jiang, Y. Hu, Y. Liu, W. Xian (Guangzhou, China)
Association between MAPT haplotype and hippocampal repetition suppression in Parkinson’s disease

E. Yoon, T. Alrazi, M. Ramezani, I. Kathol, J. Sarna, T. Hammer, L. Derwent, J. Cheetham, Z. Gan-Or, G. Rouleau, O. Monchi (Calgary, AB, Canada)
Association between peripheral inflammation and DATSCAN data of the striatal nuclei in different motor subtypes of Parkinson Disease

H. Sanjari Moghaddam, F. Ghazi Sherbaf, M H. Aarabi, M. Mojtahed Zadeh (Tehran, Islamic Republic of Iran)
Association between serum Vitamin D levels and Parkinson’s disease: A systematic review and meta-analysis

XY. Luo, R. Ou, HF. Shang (Chengdu, China)
Association between sleep duration and subsequent risk of Parkinson´s disease and survival: Data from NEDICES study

R. López-Blanco, A. Sánchez-Ferro, J. Benito-León, F. Bermejo-Pareja, E. de Pablo-Fernández (Alcalá de Henares, Spain)
Association of GALC, ZNF184 and rs2280104 with PD in southern Chinese

G. Li, J. Liu, S.S. Cui, J.J. Du, P.C. Zhang, J.F. Ma, S.D. Chen (Shanghai, China)
Association of GBA polymorphisms and mutations with dementia in Parkinson disease: A 7-year study of three population-based incident cohorts

K. Lunde, J. Chung, I. Dalen, K. Pedersen, J. Linder, M. Domellöf, E. Elgh, A. Macleod, C. Tzoulis, J. Larsen, O. Tysnes, L. Forsgren, C. Counsell, G. Alves, J. Maple-Grødem (Stavanger, Norway)
Association of impaired melatonin secretion with sleep disturbance in multiple system atrophy

T. Nakamura, M. Ueda, M. Suzuki, E. Imai, G. Tohnai, M. Katsuno (Nagoya, Japan)
Association of Olfaction dysfunction with Brain Microstructure in Prodromal Parkinson disease

H. Sanjari Moghaddam, M.H. Aarabi, Z. Valitabar (Tehran, Islamic Republic of Iran)
Asymmetric olfactory deficit in H&Y stage-1 early onset Parkinson’s disease

J. Wang, R. Stanford, L. Spreen, T. Subramanian, Q. Yang (Hershey, PA, USA)
Asymmetry of pallidal neuronal activity correlates with head rotation in patients with cervical dystonia

A. Sedov, U. Semenova, V. Myrov, S. Usova, A. Gamaleya, A. Tomskiy, H. Jinnah, A. Shaikh (Moscow, Russian Federation)
Asynchronous Consultation in Movement Disorders: The East Africa Hub

M. Dekker, S. Urasa, S. Guttman, W. Howlett, M. Guttman (Moshi, United Republic of Tanzania)
Asynchronous Telehealth Consultations for Movement Disorders in Africa

J. Guenther, M. Katz, E. Cubo, N. Galifianakis, S. Guttman, N. Okubadejo, M. Spindler, J. Aldred, M. Guttman (San Francisco, CA, USA)
Ataxia and cerebellar atrophy in Charcot-Marie-Tooth neuropathy type 4C

M. Paucar, H. Skott, K. Samuelsson, H. Malmgren, G. Solders, P. Svenningsson (Stockholm, Sweden)
Attitudes to Palliative Care in Movement Disorder Physicians in the UK

L. Wiblin, T. Wong, C. Kui, M. Lee, D. Burn (Newcastle-upon-Tyne, United Kingdom)
Attitudes toward earlier use of deep brain stimulation among patients with Parkinson’s disease

L. Cabrera, C. Sidiropoulos (East Lansing, MI, USA)
Atypical Dopamine Responsive Parkinsonism in HIV Seroconversion

N. Siddi Ganie, I. Siddi Ganie, N. Soni (Durban, South Africa)
Atypical glutaric aciduria type 1 with hemidystonia and asymmetric radiological findings misdiagnosed as an ischemic stroke

D. Demailly, C. Vianey-Saban, C. Acquaviva, V. Gonzalez, I. De Antonio, F. Cyprien, T. Roujeau, A. Masoliver, N. Leboucq, P. Coubes, L. Cif (Montpellier, France)
Atypical presentation in 4 patients of Subacute Sclerosing Pan Encephalitis (SSPE), –widening phenotypic horizon

P. Basu, A. Ghosal, S. Shubham, J. Ganguly, Y. Kumar, K. Kumar (Kolkata, India)
Atypical presentation of PANK2 mutation: A case report

M. Sousa, R. Varela, A. Morgadinho, C. Januário (Coimbra, Portugal)
Atypical Response to Apomorphine in a Patient with Multiple System Atrophy

S. Ozben, F. Genc, F. Tuter Yilmaz, A. Erdal, N. Atis (Antalya, Turkey)
Auditory rhythmic cueing changes motor control during walking in Parkinson’s disease

A. Islam, C. Chen, l. Alcock, K. Nazarpour, L. Rochester, A. Pantall (Newcastle-upon-Tyne, United Kingdom)
Augmented Reality-Based Dance Application on Balance and Mobility of Individuals with Parkinson’s Disease: A Pilot Study

T. Tunur, K. Rickford, A. DeBlois, E. Horton-Yates, L. Columna (San Marcos, CA, USA)
Auto-antibodies and clinical-imaging associations in patients with Movements Disorders from a Neurological Institute in Mexico

H. Martinez-Hernandez, N. Gandarilla-Martinez, J. Flores-Rivera, O. Cardenas-Saenz, R. Garcia-Santos, V. Rivas, N. Kerik-Rotenberg, S. Vargas-Cañas, M. Espinola-Nadurille (Mexico City, Mexico)
Automated Differential Diagnosis of Parkinsonian Syndromes Using FDG-PET Metabolic Brain Network Analysis

T. Rus, P. Tomše, L. Jensterle, M. Grmek, Z. Pirtošek, D. Eidelberg, C. Tang, M. Trošt (Ljubljana, Slovenia)
Automated immunohistochemical detection of pathological alpha-synuclein in human tissue biopsy

TS. Tsao, A. Racolta, H. Zhang, M. Robida, J. Pugh, T. Beach, T. Kremer, C. Czech, K. Taylor, W. Zago, L. Pestic-Dragovich, L. Tang, S. Dziadek (Tucson, AZ, USA)
Autonomic Dysfunction in Parkinson’s Disease: Role of New Surrogate Markers

S. Menon R, A. Lutterotti (Ernakulam, India)
Autosomal dominant PANK2 mutation resulting in cervical dystonia with iron accumulation in the basal ganglia

M. van_der_Weijden, R. Lambrechts, E. Nibbeling, J. Groen, T. de Koning, O.. Sibon, M. Tijssen, D. Verbeek (Groningen, Netherlands)